The company is a prominent pharmaceutical group established in 1971, dedicated to providing high-quality and effective healthcare products and services. With over 20 subsidiaries and more than 16,000 employees across major cities, the company emphasizes innovation and quality, operating four national R&D platforms. Recognized for its excellence, it has won multiple State Science and Technology Advancement Awards and holds international standards for Chinese medicinal materials included in the European Pharmacopoeia. The company focuses on quality-first and efficiency-priority principles, aiming to enhance health outcomes while continuously advancing in the global healthcare industry.

The company is a prominent pharmaceutical group established in 1971, dedicated to providing high-quality and effective healthcare products and services. With over 20 subsidiaries and more than 16,000 employees across major cities, the company emphasizes innovation and quality, operating four national R&D platforms. Recognized for its excellence, it has won multiple State Science and Technology Advancement Awards and holds international standards for Chinese medicinal materials included in the European Pharmacopoeia. The company focuses on quality-first and efficiency-priority principles, aiming to enhance health outcomes while continuously advancing in the global healthcare industry.

This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.